Privigen is proven effective—and is the first and only IVIg formulated with proline stabilization

Clinical significance is unknown.

See efficacy and safety in:

See additional benefits of Privigen

Support for you and your patients. All in one place.

CSL Behring is committed to helping you and your patients by providing valuable live support with reimbursement, insurance, and financial assistance needs.

Access the recommended dosing and infusion rates for your patients

Use the convenient dosing calculator or download the PDF.

See dosing and infusion rates for PI, CIDP, or chronic ITP

See information just for patients

Learn how Privigen treats PI, chronic ITP, and CIDP, and get helpful tips on living with these conditions.

Get information on PI, CIDP, or chronic ITP

Reference: 1. Data on file. Available from CSL Behring as DOF PVG-006.

You are now leaving the current website.

Do you want to continue?